Cardiologie
Het belangrijkste doel van farmacologische behandelingen is om de impact op het dagelijks leven van HCM te verminderen5
Comorbiditeiten en sterfte
Wat zijn de mogelijke complicaties van HCM? Lees meer over het risico op comorbiditeiten en sterfte.
Diagnose
Lees hier over de diagnose van HCM.
Meer weten over HCM
Referenties
1. Huff CM, Turer AT, Wang A. Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy. Qual Life Res. 2013;22(3):647-652.
2. Cox S, O’Donoghue AC, McKenna WJ, Steptoe A. Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart. 1997;78(2):182-187.
3. Zaiser E, Sehnert AJ, Duenas A, Saberi S, Brookes E, Reaney M. Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life. J Patient Rep Outcomes. 2020;4(1 ):102.
4. Luiten RC, Ormond K, Post L, Asif IM, Wheeler MT, Caleshu C. Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy. Open Heart. 2016;3(2):e000488.
5. Ammirati E, Contri R, Coppini R, Cecchi F, Frigerio M, Olivotto I. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. EurJ Heart Fail. 2016;18(9):1106-1118.